Molecules/NIRSEVIMAB

NIRSEVIMAB

Molecular Identity

AntibodyApprovedFirst approved 2022

Mechanism of action: Fusion glycoprotein F0 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

BEYFORTUSMED-18897MEDI8897NIRSEVIMABNIRSEVIMAB-ALIP

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to NIRSEVIMAB

Loading drug network...